Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension.

BACKGROUND Primary pulmonary hypertension (PPH) is a rare disease of unknown cause. Although PPH and secondary pulmonary hypertension (SPH) share many clinical and pathological characteristics, their origins may be disparate. In pulmonary artery smooth muscle cells (PASMCs), the activity of voltage-gated K+ (KV) channels governs membrane potential (Em) and regulates cytosolic free Ca2+ concentration ([Ca2+]cyt). A rise in [Ca2+]cyt is a trigger of vasoconstriction and a stimulus of smooth muscle proliferation. METHODS AND RESULTS Fluorescence microscopy and patch clamp techniques were used to measure [Ca2+]cyt, Em, and KV currents in PASMCs. Mean pulmonary arterial pressures were comparable (46+/-4 and 53+/-4 mm Hg; P=0.30) in SPH and PPH patients. However, PPH-PASMCs had a higher resting [Ca2+]cyt than cells from patients with SPH and nonpulmonary hypertension disease. Consistently, PPH-PASMCs had a more depolarized Em than SPH-PASMCs. Furthermore, KV currents were significantly diminished in PPH-PASMCs. Because of the dysfunctional KV channels, the response of [Ca2+]cyt to the KV channel blocker 4-aminopyridine was significantly attenuated in PPH-PASMCs, whereas the response to 60 mmol/L K+ was comparable to that in SPH-PASMCs. CONCLUSIONS These results indicate that KV channel function in PPH-PASMCs is inhibited compared with SPH-PASMCs. The resulting membrane depolarization and increase in [Ca2+]cyt lead to pulmonary vasoconstriction and PASMC proliferation. Our data suggest that defects in PASMC KV channels in PPH patients may be a unique mechanism involved in initiating and maintaining pulmonary vasoconstriction and appear to play a role in the pathogenesis of PPH.

[1]  L. Shimoda,et al.  Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[2]  M. Juhaszova,et al.  Attenuated K+ channel gene transcription in primary pulmonary hypertension , 1998, The Lancet.

[3]  L. Shimoda,et al.  Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1. , 1998, The American journal of physiology.

[4]  M. Deitel Appetite-suppressant Drugs and the Risk of Primary Pulmonary Hypertension? , 1997, Obesity surgery.

[5]  J. Benichou,et al.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension , 1997 .

[6]  S. Archer,et al.  Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. , 1996, Circulation.

[7]  M. Blaustein,et al.  NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Wilke,et al.  Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. , 1996, The New England journal of medicine.

[9]  J. Hoidal,et al.  Potassium currents in cultured human pulmonary arterial smooth muscle cells. , 1996, Journal of applied physiology.

[10]  P. Pratt,et al.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.

[11]  M. Rekhter,et al.  Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types. , 1995, Circulation research.

[12]  X. J. Yuan,et al.  Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. , 1995, Circulation research.

[13]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[14]  M. Berridge,et al.  Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  M. Nelson,et al.  Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.

[16]  D. Clapham,et al.  Calcium signaling , 1995, Cell.

[17]  N. Allbritton,et al.  Source of nuclear calcium signals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Fleischmann,et al.  Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Trimmer,et al.  Dexamethasone rapidly induces Kv1.5 K+ channel gene transcription and expression in clonal pituitary cells , 1993, Neuron.

[20]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[21]  P. Davies,et al.  Mechanical stress mechanisms and the cell. An endothelial paradigm. , 1993, Circulation research.

[22]  V. S. Zhdanov,et al.  [Pathology of primary pulmonary hypertension]. , 1993, Arkhiv patologii.

[23]  B. Groves,et al.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.

[24]  S. Rich,et al.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.

[25]  J. Wallwork,et al.  Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. , 1991, The New England journal of medicine.

[26]  R. Virmani,et al.  The pathology of primary pulmonary hypertension. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[27]  J B Patlak,et al.  Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. , 1990, The American journal of physiology.

[28]  H. Palevsky,et al.  Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. , 1989, Circulation.

[29]  D. Buff Primary pulmonary hypertension. , 1987, Annals of internal medicine.

[30]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[31]  Wagenvoort Ca The pathology of primary pulmonary hypertension. , 1970 .

[32]  P. Wood PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR* , 1958, British heart journal.